{
  "report_rows": [
    {
      "kpi": "Adjusted EBITDA (Total Company)",
      "prediction": "BEAT",
      "answer": "pred ~$1.35B vs. cons $1.22B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.55 vs. cons $1.35",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "O&P-Americas Segment EBITDA",
      "prediction": "BEAT",
      "answer": "pred ~$550M vs. cons $470M",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Q3 2026 EBITDA/Pricing Momentum Commentary",
      "prediction": "LOWER",
      "answer": "guide ~flat-to-down qoq tone vs. cons expecting sequential improvement (Q3 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "O&P-Americas Utilization/PE-PP Spread Trajectory",
      "prediction": "UNCHANGED",
      "answer": "guide ~90% utilization achieved, PE/PP spreads holding near guided levels vs. cons assuming continued spread expansion (Q2 2026 actual / Q3 commentary)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "I&D Bayport PO/TBA Restart Timing",
      "prediction": "UNCHANGED",
      "answer": "guide ~restart completed by quarter-end as promised vs. cons expecting on-time restart (Q2 2026)",
      "confidence": "LOW"
    },
    {
      "kpi": "Capital Allocation / Dividend Policy",
      "prediction": "UNKNOWN",
      "answer": "guide ~debt paydown priority maintained, no near-term dividend restoration vs. cons hoping for capital return signal (FY2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 2.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -1.5,
  "day5_path": "FADE",
  "day5_rationale": "Q2 results likely beat on the Middle East-driven pricing catch-up (PE/PP spreads, Bayport restart), consistent with the Dow/Eastman beat pattern already seen in peers, supporting a positive day-1 pop as LYB re-rates off deeply oversold levels (stock down from $82 ATH to low-$50s before this week's bounce to ~$60 on fresh Iran escalation. However, DOW and OLN's soft Q3 guides (both well below consensus) signal the sell-side will apply the same skepticism to LYB's forward commentary: any hint that PE/PP price gains are decelerating into Q3, or that the Bayport restart benefit is largely already realized, will drive out-period estimate cuts even after a Q2 beat. Given LYB's higher leverage to the same input-cost/pricing dynamics and its own admission of soft APS/auto demand and still-weak Technology licensing, the initial pop is likely to fade over the following days as analysts model a step-down in H2 EBITDA, especially if Middle East risk premium volatility (whipsawing the stock 90% peak-to-trough already this year) proves unstable rather than a durable structural re-rating catalyst.",
  "day5_confidence": "LOW"
}